BioNexus Gene Lab Corp Common stock (BGLC) had the highest return between 2013 and 2022 by a US stock, returning 2,780,387.8%.

ASSET	YEARS	% RETURN
BioNexus Gene Lab Corp Common stock (BGLC)	2013-2022	2,780,387.8%
LMF Acquisition Opportunities (ICU)	2013-2022	2,614,695.92%
KULR Technology (KULR)	2013-2022	2,399,900%
Next Technology (NXTT)	2013-2022	1,162,346.87%
INVO Fertility (IVF)	2013-2022	508,700%
Connexa Sports Technologies (YYAI)	2013-2022	467,900%
GeoVax Labs (GOVX)	2013-2022	325,762.07%
Heart Test Laboratories Inc Common Stock (HSCS)	2013-2022	246,958.82%
MDxHealth SA ADR (MDXH)	2013-2022	220,233.33%
AquaBounty Technologies (AQB)	2013-2022	212,122.22%
Immatics (IMTX)	2013-2022	174,100%
Iqstel (IQST)	2013-2022	146,895.96%
Eastside Distilling (BLNE)	2013-2022	137,437.54%
Integra Resources (ITRG)	2013-2022	126,500%
Aurora Cannabis (ACB)	2013-2022	122,966.67%
Blackboxstocks (BLBX)	2013-2022	70,488.24%
Helport AI Limited Ordinary Shares (HPAI)	2013-2022	67,300%
Applied Digital (APLD)	2013-2022	63,348.28%
Celsius (CELH)	2013-2022	37,070.42%
Xpel (XPEL)	2013-2022	32,364.86%
TCTM Kids IT Education (VSA)	2013-2022	30,555.11%
SurgePays (SURG)	2013-2022	29,718.18%
Processa Pharmaceuticals (PCSA)	2013-2022	26,090.48%
Guardforce AI (GFAI)	2013-2022	24,323.08%
FingerMotion (FNGR)	2013-2022	22,380%